GlaxoSmithkline Consumer Healthcare Ltd on Tuesday reported a Rs 192-crore net profit for the second quarter (Q2) of fiscal 2017-18, registering a marginal 4.3 per cent annual growth from Rs 184 crore in the same period last year.
Sequentially, however, the net profit for Q2 is 46 per cent up from Rs 132 crore posted in the last quarter.
In a regulatory filing on the BSE, the NCR-based company said the revenue from operations at Rs 1,115 crore for Q2 was 6.5 per cent annually lower than Rs 1,193 crore in the like period of last year but up 6.6 per cent sequentially from Rs 1,046 crore in the last quarter.
The blue chip company's scrip of Rs 10 face value lost Rs 43 per share in Tuesday's trading on the BSE to end at Rs 5,466.05 from Monday's closing rate of Rs 5,509.65 and opening price of Rs 5,549.95.
--IANS
fb/nir/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
